“…CRT-D may confer greater benefits to women than to men in the setting of NICM and LBBB. 175 , 176 , 177 , 178 Subgroup analysis of the M ulticenter A utomatic D efibrillator I mplantation T rial With C ardiac R esynchronization T herapy (MADIT-CRT) study identified women as exceptional responders to CRT, with a 72% decrease in all-cause mortality and greater reduction in left atrial and ventricular volumes. 178 Despite men typically being younger at diagnosis, in a retrospective study conducted by Wang et al., women were found to have a lower risk of death, compared with men in LBBB-associated NICM, after controlling for age at diagnosis.…”